Drugbank Logo

Search Results

Search for "Tipranavir" returned 8 results

Showing 1-8 out of 8
DrugBank ID Name Formula Weight
DB00932
DrugCard button for DB00932
Tipranavir C31H33F3N2O5S 602.6640
Monitor for decreased Tipranavir efficacy. Pimozide Tipranavir, co-administered with Ritonavir, may increase the plasma concentration of Pimozide. Concomitant therapy is contraindicated ...
DB00900
DrugCard button for DB00900
Didanosine C10H12N4O3 236.2273
... Tenofovir increases the effect and toxicity of didanosine Tipranavir Didanosine EC levels may be reduced Valganciclovir The antiviral agent increases the effect and toxicity of didanosine ...
DB01048
DrugCard button for DB01048
Abacavir C14H18N6O 286.3323
The antiviral response should be closely monitored. Tipranavir The serum concentration of Abacavir may be decreased by protease inhibitors such as Tipranavir. The antiviral response should be ...
DB00243
DrugCard button for DB00243
Ranolazine C24H33N3O4 427.5365
... Thioridazine Possible additive effect on QT prolongation Tipranavir Increased levels of ranolazine - risk of toxicity Verapamil Increased levels of ranolazine - risk of toxicity Voriconazole ...
DB00862
DrugCard button for DB00862
Vardenafil C23H32N6O4S 488.6030
... changes in the therapeutic and adverse effects of Vardenafil if Tipranavir is initiated, discontinued or dose changed. Voriconazole Voriconazole, a strong CYP3A4 inhibitor, may reduce the ...
DB00820
DrugCard button for DB00820
Tadalafil C22H19N3O4 389.4040
Monitor for hypotension during concomitant therapy. Tipranavir Tipranavir may reduce the metabolism of Tadalafil. Concomitant therapy should be avoided if possible due to high risk of Tadalafil ...
DB00864
DrugCard button for DB00864
Tacrolimus C44H69NO12 804.0182
... for changes in the therapeutic/toxic effects of Tacrolimus if Tipranavir therapy is initiated, discontinued or altered. Tobramycin Additive renal impairment may occur during concomitant ...
DB00656
DrugCard button for DB00656
Trazodone C19H22ClN5O 371.8640
Monitor for changes in Trazodone efficacy/toxicity if Tipranavir is initiated, discontinued or dose changed. Tolterodine The 2D6 inhibitor, Trazodone, may increase the efficacy of Tolterodine by ...
Showing 1-8 out of 8

This project is supported by Genome Alberta & Genome Canada, a not-for-profit organization that is leading Canada's national genomics strategy with $600 million in funding from the federal government. This project is also supported in part by GenomeQuest, Inc., an enterprise genomic information company serving the life science community.